Monday, 11 November 2019

AstraZeneca succeeds in treating lupus in late-stage study

AstraZeneca Plc said on Monday its experimental treatment significantly reduced disease activity in patients with autoimmune disorder lupus, in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)